Every engagement is led personally by Barb Senters, CCEP, CHC, PHR — no hand-offs to junior staff.
Interim/Fractional CCO Leadership
LeadershipOn-demand Chief Compliance Officer leadership for labs navigating transitions, rapid growth, or regulatory scrutiny. We provide experienced oversight of OIG compliance program elements, medical necessity policies, and lab-specific billing compliance — without the cost of a full-time executive hire.
Especially critical when a lab is under MAC audit, responding to an OIG inquiry, or scaling operations faster than internal compliance can keep pace.
Compliance Program Design & Enhancement
Program DesignWe design and build compliance programs structured around the OIG's Seven Elements of an Effective Compliance Program — the federal standard for what "effective" actually means. For clinical laboratories, that means written policies and procedures, designated compliance leadership, targeted training, open lines of communication, internal monitoring and auditing, disciplinary standards, and a clear response and corrective action process. Each element is built for your lab's specific risk profile, not copied from a template.
A Seven Elements program built for labs — covering medical necessity frameworks, CLIA infrastructure, billing and coding policies, and OIG audit readiness. Built to hold up under scrutiny, not just on paper.
Risk Assessments
Risk & AuditComprehensive, risk-based assessments that identify compliance gaps and prioritize remediation. For clinical labs, this means targeted review of medical necessity documentation, ordering physician relationships, test utilization patterns, and billing practices — benchmarked against OIG work plan priorities and current enforcement trends.
Our proprietary methodology is published as a best practice by the Health Care Compliance Association.
Regulatory Remediation
Enforcement ResponseStrategic guidance for organizations under regulatory oversight — including OIG Corporate Integrity Agreements, DOJ investigations, MAC audits, RAC audits, and other enforcement actions. We led the successful exit of a CIA that the OIG specifically praised for its innovative whistleblower engagement strategy.
If you're already in the crosshairs, this is where our track record matters most.
Expert Witness Services
Litigation SupportQualified expert witness testimony and analysis in complex compliance, fraud, and regulatory matters — including False Claims Act cases, medical necessity disputes, and laboratory billing litigation. We bring deep subject matter expertise and a credible track record to litigation and dispute resolution engagements.
Retained in FCA cases, medical necessity disputes, and lab billing litigation nationwide.
M&A Due Diligence & Integration
TransactionsCompliance-focused due diligence and post-close integration support for mergers, acquisitions, and private equity transactions. We have supported deals exceeding $1.5 billion, including transactions involving laboratory and healthcare services businesses where billing compliance and regulatory exposure are central to deal risk.
Lab acquisitions carry hidden compliance risk. We surface it before it becomes your problem.
Board-Level Reporting & Advisory
GovernanceExecutive-ready compliance reporting, board presentations, and advisory services that translate complex regulatory risk into clear, actionable intelligence for leadership and governance bodies — including lab owners, PE-backed management teams, and public company boards.
Boards need to understand lab compliance risk in plain language. We make that happen.
IPO & Public Company Readiness
TransactionsEnd-to-end compliance program design and SEC readiness support for companies preparing to go public. We built and guided Core Scientific's GRC program through rigorous SEC scrutiny ahead of its Nasdaq launch — the same structured approach applies to healthcare and lab companies on a public company path.
Lab companies going public face unique compliance disclosure requirements. We've navigated them.